Literature DB >> 26849025

Bile ductal injury and ductular reaction are frequent phenomena with different significance in autoimmune hepatitis.

Robert C Verdonk1, Mallaki F Lozano2, Aad P van den Berg1, Annette S H Gouw2.   

Abstract

BACKGROUND & AIMS: The significance of bile duct injury and ductular reaction in biopsies from autoimmune hepatitis patients is not clear. We aim to establish the prevalence and clinical relevance of both phenomena in autoimmune hepatitis.
METHODS: Cases of newly diagnosed, untreated autoimmune hepatitis without overlap syndrome were selected. Pretreatment and follow up biopsies were scored for inflammation, fibrosis, bile ductal injury and ductular reaction.
RESULTS: Thirty-five cases were studied of whom 14 cases had follow up biopsies. Bile duct injury was present in 29 cases (83%), mostly in a PBC-like pattern and was not correlated with demographical or laboratory findings. Ductular reaction, observed in 25 of 35 cases (71%) using conventional histology and in 30 of 32 cases (94%) using immunohistochemistry, was correlated with portal and lobular inflammation, interface hepatitis and centrilobular necrosis as well as bile duct injury and fibrosis. In 11 of 14 cases (79%) ductular reaction remained present on post-treatment biopsy whereas bile duct injury persisted in six of 14 (43%) of cases.
CONCLUSIONS: Bile duct injury and ductular reaction are very common in newly diagnosed autoimmune hepatitis and cannot be predicted biochemically. Bile duct injury may subside in the majority of treated AIH cases while DR tends to persist during follow up. These findings show that the two phenomena are part of the spectrum of AIH with dissimilar responses to treatment and do not necessarily point towards an overlap syndrome. Persistence of ductular reaction after treatment supports the notion that it represents a regenerative response.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PBC-like; PSC-like; autoimmune hepatitis; bile duct injury; ductular reaction; overlap syndrome; progenitor cells; simplified score

Mesh:

Year:  2016        PMID: 26849025     DOI: 10.1111/liv.13083

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  7 in total

1.  Biliary features in liver histology of children with autoimmune liver disease.

Authors:  Angelo Di Giorgio; A D'Adda; A Marseglia; A Sonzogni; L Licini; E Nicastro; L D'Antiga
Journal:  Hepatol Int       Date:  2019-05-08       Impact factor: 6.047

Review 2.  Autoimmune hepatitis: current challenges and future prospects.

Authors:  Yoshio Aizawa; Atsushi Hokari
Journal:  Clin Exp Gastroenterol       Date:  2017-01-19

3.  Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.

Authors:  Lindsey Kennedy; Vik Meadows; Jennifer Demieville; Laura Hargrove; Shohaib Virani; Shannon Glaser; Tianhao Zhou; Evan Rinehart; Victoria Jaeger; Konstantina Kyritsi; Linh Pham; Gianfranco Alpini; Heather Francis
Journal:  Lab Invest       Date:  2020-02-13       Impact factor: 5.662

Review 4.  Pathology of autoimmune hepatitis.

Authors:  Claudia Covelli; Diana Sacchi; Samantha Sarcognato; Nora Cazzagon; Federica Grillo; Francesca Baciorri; Daniela Fanni; Matilde Cacciatore; Valeria Maffeis; Maria Guido
Journal:  Pathologica       Date:  2021-06

Review 5.  Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.

Authors:  Samantha Sarcognato; Diana Sacchi; Federica Grillo; Nora Cazzagon; Luca Fabris; Massimiliano Cadamuro; Ivana Cataldo; Claudia Covelli; Alessandra Mangia; Maria Guido
Journal:  Pathologica       Date:  2021-06

6.  Direct Conversion of Mouse Fibroblasts into Cholangiocyte Progenitor Cells.

Authors:  Kyung Tae Lim; Jonghun Kim; Seon In Hwang; Ludi Zhang; Heonjong Han; Dasom Bae; Kee-Pyo Kim; Yi-Ping Hu; Hans R Schöler; Insuk Lee; Lijian Hui; Dong Wook Han
Journal:  Stem Cell Reports       Date:  2018-03-29       Impact factor: 7.765

7.  AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.

Authors:  Haoyang Zhu; Yichao Chai; Dinghui Dong; Nana Zhang; Wenyan Liu; Tao Ma; Rongqian Wu; Yi Lv; Liangshuo Hu
Journal:  Can J Gastroenterol Hepatol       Date:  2018-12-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.